Notably, and in contrast to patients with IPEX or LRBA deficiency, CTLA-4-deficient patients seem to show a later disease manifestation during their second decade of life. This evidence concerns the gene CTLA4 and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome.